Status | Study |
Recruiting |
Study Name: Carotid Intima Media Thickness (CIMT) in Epistaxis Condition: Epistaxis Atherosclerosis Date: 2017-03-22 Interventions: Diagnostic Test: Ultrasound |
Recruiting |
Study Name: Topical Intranasal Tranexamic Acid for Epistaxis in the Emergency Department Condition: Epistaxis Date: 2016-10-10 Interventions: Drug: Tranexamic Acid TXA (100 |
Not yet recruiting |
Study Name: Treatment of Nasal Staphylococcus Aureus Colonization in Patients With HHT Condition: Hereditary Hemorrhagic Telangiectasia Epistaxis Date: 2016-08-09 Interventions: Drug: Mupirocin Mupirocin oint |
Not yet recruiting |
Study Name: Correlation Between Epistaxis and Cardiovascular Disease Condition: Cardiovascular Disease Epistaxis Date: 2016-01-31 Interventions: Biological: Blood-pressure variability Day to Night Blood pressure variability |
Recruiting |
Study Name: Prospective Pilot Study of Floseal for the Treatment of Anterior Epistaxis in Patients With (HHT) Condition: Hereditary Hemorrhagic Telangiectasia (HHT) Epistaxis Date: 2015-10-13 Interventions: Drug: Floseal Topical lidocain |
Recruiting |
Study Name: Management of Persistent Epistaxis Using Floseal Hemostatic Matrix Condition: Epistaxis Date: 2015-06-26 Interventions: Device: Floseal Hemostatic Matrix |
Withdrawn |
Study Name: Microporous Polysaccharide Hemospheres Epistaxis Condition: Epistaxis Date: 2015-06-05 Interventions: Device: Microporous Polysaccharide Hemospheres |
Recruiting |
Study Name: , "Mucosal Injury During Nasotracheal Intubation for Dental Procedures in Children-does the Tube Design Matter?" Condition: Epistaxis Date: 2015-05-22 Interventions: Device: Parker flex-tip nasotracheal tube |
Recruiting |
Study Name: Intranasal Bevacizumab for HHT-Related Epistaxis Condition: HHT Hereditary Hemorrhagic Telangiectasia Date: 2015-03-11 Interventions: Drug: Bevacizumab Bevacizumab |
Completed |
Study Name: Hemoglobin and INR Out of Nose Blood Condition: Epistaxis Date: 2015-02-17 |